|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print November 29, 2001
Am J Physiol Regu Physiol, 10.1152/ajpregu.00520.2001
Submitted on August 30, 2001
Accepted on November 24, 2001
1 Department of Anesthesiology, University of Regensburg, Regensburg, Germany
2 Department of Physiology, University of Regensburg, Regensburg, Germany
* To whom correspondence should be addressed. E-mail: michael.bucher{at}klinik.uni-regensburg.de.
The reduced pressure response to vasopressin during acute sepsis has directed our interest onto the regulation of vasopressin V1A-receptors. Rats were injected with lipopolysaccharide for induction of experimental Gram-negative sepsis. V1A-receptor gene expression was downregulated in the liver, lung, kidney and heart during endotoxemia. As the concentrations of proinflammatory cytokines such as IL-1ß, TNF-
and IFN-
were highly increased during sepsis the influence of these cytokines on V1A-receptor expression was investigated in primary cultures of hepatocytes and in the aortic vascular smooth muscle cell line A7r5. It turned out that V1A-receptor expression was downregulated by the cytokines in a nitric oxide-independent manner. Blood pressure dose-response studies after injection of endotoxin showed a diminished responsiveness to the selective V1-receptor agonist Phe2, Ile3, Orn8-vasopressin. Our data show that sepsis causes a downregulation of V1A-receptors, and suggest that this effect is likely mediated by proinflammatory cytokines. We propose that this downregulation of V1A-receptors contributes to the attenuated responsiveness of blood pressure in response to vasopressin, and therefore contributes to the circulatory failure in septic shock.
This article has been cited by other articles:
![]() |
S. Novella, A. C. Martinez, R. M. Pagan, M. Hernandez, A. Garcia-Sacristan, A. Gonzalez-Pinto, J. M. Gonzalez-Santos, and S. Benedito Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmidt, K. Hocherl, and M. Bucher Cytokine-mediated regulation of urea transporters during experimental endotoxemia Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1479 - F1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sandbo, S. Taurin, D. M. Yau, S. Kregel, R. Mitchell, and N. O. Dulin Downregulation of smooth muscle {alpha}-actin expression by bacterial lipopolysaccharide Cardiovasc Res, May 1, 2007; 74(2): 262 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmidt, K. Hocherl, F. Schweda, A. Kurtz, and M. Bucher Regulation of Renal Sodium Transporters during Severe Inflammation J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1072 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmidt, K. Hocherl, and M. Bucher Regulation of renal glucose transporters during severe inflammation Am J Physiol Renal Physiol, February 1, 2007; 292(2): F804 - F811. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Westphal, A. W. Sielenkamper, H. Van Aken, H. D. Stubbe, F. Daudel, R. Schepers, S. Schulte, and H.-G. Bone Dopexamine Reverses the Vasopressin-Associated Impairment in Tissue Oxygen Supply but Decreases Systemic Blood Pressure in Ovine Endotoxemia Anesth. Analg., September 1, 2004; 99(3): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. P. van Haren, F. W. Rozendaal, and J. G. van der Hoeven The Effect of Vasopressin on Gastric Perfusion in Catecholamine-Dependent Patients in Septic Shock Chest, December 1, 2003; 124(6): 2256 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Lohmeier Neurohypophysial hormones Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R715 - R717. [Full Text] [PDF] |
||||
![]() |
K. Hocherl, F. Dreher, A. Kurtz, and M. Bucher Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure Hypertension, December 1, 2002; 40(6): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer and C. A. Singer Secretory Functions of Smooth Muscle: Cytokines and Growth Factors Mol. Interv., November 1, 2002; 2(7): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |